Harvard's xenotransplantation technology developer eGenesis has raised a $100m in its series B round.

Leaps by Bayer has put $50m into xenotransplantation technology developer eGenesis as part of a $100m series B round that followed a $38m series A backed by Heritage Provider Network.

Okta Ventures supplied a share of the cash for software engagement analytics platform Productiv, which last raised funding in March 2019.

Axis Capital and CNO Financial Group invested in health insurance portal Healthcare.com’s second funding round, proceeds of which will support product development and other growth objectives.

The Inserm spinout secured a $7.8m series B extension and boosted its portfolio with the acquisition of AVCare, a Satt Ouest Valorisation-allied business.

Health provision integration platform Healthify has now raised $28m in equity and grants after a series B round involving BlueCross BlueShield Venture Partners.

Honeywell Ventures was among the investors in drug manufacturing informatics company Bigfinite’s latest round, with the proceeds slated to grow the market for its platform.

Bayer has led a $25m series B round for Medopad, which allows patients to capture healthcare data through smartphones and watches.

Merck Global Health Innovation Fund and Bristol-Myers Squibb have provided the final tranche for PathAI’s $75m series B round, adding to an earlier commitment from LabCorp.

Genomics bioinformatics platform developer PierianDx has raised capital from investors including Inova Health Systems and RTI International to advance its business strategy.